APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wearable Injectors and Connected Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Wearable Injectors and Connected Devices Market Analysis and Forecast 2026-2032

5 July 2026201 pages

Choose your research edition.

Industry ResearchWearable Injectors and Connected Devices Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Wearable Injectors and Connected Devices Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Wearable Injectors and Connected Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wearable Injectors and Connected Devices Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Wearable Injectors and Connected Devices Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Wearable Injectors and Connected Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Wearable Injectors and Connected Devices include Roche, Ypsomed, West Pharma, United Therapeutics, Unilife Corporation, Sonceboz, ScPharmaceuticals, Owen Mumford and Noble International, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Wearable Injectors and Connected Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Wearable Injectors and Connected Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Wearable Injectors and Connected Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Wearable Injectors and Connected Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Wearable Injectors and Connected Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Wearable Injectors and Connected Devices sales, projected growth trends, production technology, application and end-user industry.

Wearable Injectors and Connected Devices Segment by Company

Roche

Ypsomed

West Pharma

United Therapeutics

Unilife Corporation

Sonceboz

ScPharmaceuticals

Owen Mumford

Noble International

Insulet

Gerresheimer

Enable Injections

Elcam Medical

Eitan Medical

CeQur

BD Medical

Amgen

Wearable Injectors and Connected Devices Segment by Type

Disposable

Reusable

Wearable Injectors and Connected Devices Segment by Application

Home Care Settings

Hospitals

Clinics

Others

Wearable Injectors and Connected Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Injectors and Connected Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wearable Injectors and Connected Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Injectors and Connected Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Wearable Injectors and Connected Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Wearable Injectors and Connected Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Wearable Injectors and Connected Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Disposable Major Manufacturers Table 3. Reusable Major Manufacturers Table 4. Global Wearable Injectors and Connected Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Home Care Settings Major Manufacturers Table 6. Hospitals Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Others Major Manufacturers Table 9. Wearable Injectors and Connected Devices Industry Trends Table 10. Wearable Injectors and Connected Devices Industry Drivers Table 11. Wearable Injectors and Connected Devices Industry Opportunities and Challenges Table 12. Wearable Injectors and Connected Devices Industry Restraints Table 13. Global Wearable Injectors and Connected Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2026) Table 17. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2027-2032) Table 18. Global Wearable Injectors and Connected Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Wearable Injectors and Connected Devices Sales by Region (2021-2026) & (k units) Table 20. Global Wearable Injectors and Connected Devices Sales by Region (2027-2032) & (k units) Table 21. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2026) Table 22. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2027-2032) Table 23. Global Wearable Injectors and Connected Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Wearable Injectors and Connected Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2021-2026) Table 27. Global Wearable Injectors and Connected Devices Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Wearable Injectors and Connected Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Wearable Injectors and Connected Devices Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Wearable Injectors and Connected Devices Manufacturers, Product Type & Application Table 31. Global Wearable Injectors and Connected Devices Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Wearable Injectors and Connected Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Wearable Injectors and Connected Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2026) Table 38. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2027-2032) Table 39. Global Wearable Injectors and Connected Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 41. Global Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 42. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2026) Table 43. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2027-2032) Table 44. Global Wearable Injectors and Connected Devices Price by Type (2021-2026) & (USD/unit) Table 45. Global Wearable Injectors and Connected Devices Price by Type (2027-2032) & (USD/unit) Table 46. Global Wearable Injectors and Connected Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2026) Table 50. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2027-2032) Table 51. Global Wearable Injectors and Connected Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 53. Global Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 54. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2026) Table 55. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2027-2032) Table 56. Global Wearable Injectors and Connected Devices Price by Application (2021-2026) & (USD/unit) Table 57. Global Wearable Injectors and Connected Devices Price by Application (2027-2032) & (USD/unit) Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Roche Wearable Injectors and Connected Devices Product Portfolio Table 62. Roche Recent Development Table 63. Ypsomed Company Information Table 64. Ypsomed Business Overview Table 65. Ypsomed Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Ypsomed Wearable Injectors and Connected Devices Product Portfolio Table 67. Ypsomed Recent Development Table 68. West Pharma Company Information Table 69. West Pharma Business Overview Table 70. West Pharma Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. West Pharma Wearable Injectors and Connected Devices Product Portfolio Table 72. West Pharma Recent Development Table 73. United Therapeutics Company Information Table 74. United Therapeutics Business Overview Table 75. United Therapeutics Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. United Therapeutics Wearable Injectors and Connected Devices Product Portfolio Table 77. United Therapeutics Recent Development Table 78. Unilife Corporation Company Information Table 79. Unilife Corporation Business Overview Table 80. Unilife Corporation Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio Table 82. Unilife Corporation Recent Development Table 83. Sonceboz Company Information Table 84. Sonceboz Business Overview Table 85. Sonceboz Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Sonceboz Wearable Injectors and Connected Devices Product Portfolio Table 87. Sonceboz Recent Development Table 88. ScPharmaceuticals Company Information Table 89. ScPharmaceuticals Business Overview Table 90. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio Table 92. ScPharmaceuticals Recent Development Table 93. Owen Mumford Company Information Table 94. Owen Mumford Business Overview Table 95. Owen Mumford Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Owen Mumford Wearable Injectors and Connected Devices Product Portfolio Table 97. Owen Mumford Recent Development Table 98. Noble International Company Information Table 99. Noble International Business Overview Table 100. Noble International Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Noble International Wearable Injectors and Connected Devices Product Portfolio Table 102. Noble International Recent Development Table 103. Insulet Company Information Table 104. Insulet Business Overview Table 105. Insulet Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Insulet Wearable Injectors and Connected Devices Product Portfolio Table 107. Insulet Recent Development Table 108. Gerresheimer Company Information Table 109. Gerresheimer Business Overview Table 110. Gerresheimer Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Gerresheimer Wearable Injectors and Connected Devices Product Portfolio Table 112. Gerresheimer Recent Development Table 113. Enable Injections Company Information Table 114. Enable Injections Business Overview Table 115. Enable Injections Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Enable Injections Wearable Injectors and Connected Devices Product Portfolio Table 117. Enable Injections Recent Development Table 118. Elcam Medical Company Information Table 119. Elcam Medical Business Overview Table 120. Elcam Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Elcam Medical Wearable Injectors and Connected Devices Product Portfolio Table 122. Elcam Medical Recent Development Table 123. Eitan Medical Company Information Table 124. Eitan Medical Business Overview Table 125. Eitan Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Eitan Medical Wearable Injectors and Connected Devices Product Portfolio Table 127. Eitan Medical Recent Development Table 128. CeQur Company Information Table 129. CeQur Business Overview Table 130. CeQur Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. CeQur Wearable Injectors and Connected Devices Product Portfolio Table 132. CeQur Recent Development Table 133. BD Medical Company Information Table 134. BD Medical Business Overview Table 135. BD Medical Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. BD Medical Wearable Injectors and Connected Devices Product Portfolio Table 137. BD Medical Recent Development Table 138. Amgen Company Information Table 139. Amgen Business Overview Table 140. Amgen Wearable Injectors and Connected Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Amgen Wearable Injectors and Connected Devices Product Portfolio Table 142. Amgen Recent Development Table 143. North America Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 146. North America Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 147. North America Wearable Injectors and Connected Devices Sales Price by Type (2021-2026) & (USD/unit) Table 148. North America Wearable Injectors and Connected Devices Sales Price by Type (2027-2032) & (USD/unit) Table 149. North America Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 152. North America Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 153. North America Wearable Injectors and Connected Devices Sales Price by Application (2021-2026) & (USD/unit) Table 154. North America Wearable Injectors and Connected Devices Sales Price by Application (2027-2032) & (USD/unit) Table 155. North America Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 159. North America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 160. North America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 161. North America Wearable Injectors and Connected Devices Sales Price by Country (2021-2026) & (USD/unit) Table 162. North America Wearable Injectors and Connected Devices Sales Price by Country (2027-2032) & (USD/unit) Table 163. United States Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 164. Canada Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 165. Mexico Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 166. Europe Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 169. Europe Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 170. Europe Wearable Injectors and Connected Devices Sales Price by Type (2021-2026) & (USD/unit) Table 171. Europe Wearable Injectors and Connected Devices Sales Price by Type (2027-2032) & (USD/unit) Table 172. Europe Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 175. Europe Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 176. Europe Wearable Injectors and Connected Devices Sales Price by Application (2021-2026) & (USD/unit) Table 177. Europe Wearable Injectors and Connected Devices Sales Price by Application (2027-2032) & (USD/unit) Table 178. Europe Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Europe Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 183. Europe Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 184. Europe Wearable Injectors and Connected Devices Sales Price by Country (2021-2026) & (USD/unit) Table 185. Europe Wearable Injectors and Connected Devices Sales Price by Country (2027-2032) & (USD/unit) Table 186. Germany Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 187. France Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 188. U.K. Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 189. Italy Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 190. Russia Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 191. Spain Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 193. Switzerland Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 194. Sweden Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 195. Poland Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 196. China Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 197. China Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 198. China Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 199. China Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 200. China Wearable Injectors and Connected Devices Sales Price by Type (2021-2026) & (USD/unit) Table 201. China Wearable Injectors and Connected Devices Sales Price by Type (2027-2032) & (USD/unit) Table 202. China Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 203. China Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 204. China Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 205. China Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 206. China Wearable Injectors and Connected Devices Sales Price by Application (2021-2026) & (USD/unit) Table 207. China Wearable Injectors and Connected Devices Sales Price by Application (2027-2032) & (USD/unit) Table 208. Asia Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 211. Asia Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 212. Asia Wearable Injectors and Connected Devices Sales Price by Type (2021-2026) & (USD/unit) Table 213. Asia Wearable Injectors and Connected Devices Sales Price by Type (2027-2032) & (USD/unit) Table 214. Asia Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 217. Asia Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 218. Asia Wearable Injectors and Connected Devices Sales Price by Application (2021-2026) & (USD/unit) Table 219. Asia Wearable Injectors and Connected Devices Sales Price by Application (2027-2032) & (USD/unit) Table 220. Asia Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. Asia Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 225. Asia Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 226. Asia Wearable Injectors and Connected Devices Sales Price by Country (2021-2026) & (USD/unit) Table 227. Asia Wearable Injectors and Connected Devices Sales Price by Country (2027-2032) & (USD/unit) Table 228. Japan Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 229. South Korea Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 230. India Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 231. Australia Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 232. Taiwan Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units) Table 237. SAMEA Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units) Table 238. SAMEA Wearable Injectors and Connected Devices Sales Price by Type (2021-2026) & (USD/unit) Table 239. SAMEA Wearable Injectors and Connected Devices Sales Price by Type (2027-2032) & (USD/unit) Table 240. SAMEA Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units) Table 243. SAMEA Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units) Table 244. SAMEA Wearable Injectors and Connected Devices Sales Price by Application (2021-2026) & (USD/unit) Table 245. SAMEA Wearable Injectors and Connected Devices Sales Price by Application (2027-2032) & (USD/unit) Table 246. SAMEA Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 250. SAMEA Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units) Table 251. SAMEA Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units) Table 252. SAMEA Wearable Injectors and Connected Devices Sales Price by Country (2021-2026) & (USD/unit) Table 253. SAMEA Wearable Injectors and Connected Devices Sales Price by Country (2027-2032) & (USD/unit) Table 254. Brazil Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 255. Argentina Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 256. Chile Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 257. Colombia Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 258. Peru Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 260. Israel Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 261. UAE Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 262. Turkey Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 263. Iran Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 264. Egypt Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Wearable Injectors and Connected Devices Distributors List Table 268. Wearable Injectors and Connected Devices Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Wearable Injectors and Connected Devices Image Figure 2. Global Wearable Injectors and Connected Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wearable Injectors and Connected Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Disposable Image Figure 5. Reusable Image Figure 6. Global Wearable Injectors and Connected Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Wearable Injectors and Connected Devices Market Size Share 2021 VS 2025 VS 2032 Figure 8. Home Care Settings Image Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Others Image Figure 12. Global Wearable Injectors and Connected Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million) Figure 14. Global Wearable Injectors and Connected Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Wearable Injectors and Connected Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2032) Figure 17. Global Wearable Injectors and Connected Devices Sales (2021-2032) & (k units) Figure 18. Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Wearable Injectors and Connected Devices Sales YoY (2021-2032) & (k units) Figure 21. Europe Wearable Injectors and Connected Devices Sales YoY (2021-2032) & (k units) Figure 22. China Wearable Injectors and Connected Devices Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Wearable Injectors and Connected Devices Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales YoY (2021-2032) & (k units) Figure 25. Global Wearable Injectors and Connected Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Wearable Injectors and Connected Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Wearable Injectors and Connected Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Wearable Injectors and Connected Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032) Figure 31. Global Wearable Injectors and Connected Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Wearable Injectors and Connected Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032) Figure 34. Global Wearable Injectors and Connected Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Wearable Injectors and Connected Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032) Figure 37. Global Wearable Injectors and Connected Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Wearable Injectors and Connected Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032) Figure 40. North America Wearable Injectors and Connected Devices Revenue Share by Type (2021-2032) Figure 41. North America Wearable Injectors and Connected Devices Sales Share by Type (2021-2032) Figure 42. North America Wearable Injectors and Connected Devices Revenue Share by Application (2021-2032) Figure 43. North America Wearable Injectors and Connected Devices Sales Share by Application (2021-2032) Figure 44. North America Wearable Injectors and Connected Devices Revenue Share by Country (2021-2032) Figure 45. North America Wearable Injectors and Connected Devices Sales Share by Country (2021-2032) Figure 46. Europe Wearable Injectors and Connected Devices Revenue Share by Type (2021-2032) Figure 47. Europe Wearable Injectors and Connected Devices Sales Share by Type (2021-2032) Figure 48. Europe Wearable Injectors and Connected Devices Revenue Share by Application (2021-2032) Figure 49. Europe Wearable Injectors and Connected Devices Sales Share by Application (2021-2032) Figure 50. Europe Wearable Injectors and Connected Devices Revenue Share by Country (2021-2032) Figure 51. Europe Wearable Injectors and Connected Devices Sales Share by Country (2021-2032) Figure 52. China Wearable Injectors and Connected Devices Revenue Share by Type (2021-2032) Figure 53. China Wearable Injectors and Connected Devices Sales Share by Type (2021-2032) Figure 54. China Wearable Injectors and Connected Devices Revenue Share by Application (2021-2032) Figure 55. China Wearable Injectors and Connected Devices Sales Share by Application (2021-2032) Figure 56. Asia Wearable Injectors and Connected Devices Revenue Share by Type (2021-2032) Figure 57. Asia Wearable Injectors and Connected Devices Sales Share by Type (2021-2032) Figure 58. Asia Wearable Injectors and Connected Devices Revenue Share by Application (2021-2032) Figure 59. Asia Wearable Injectors and Connected Devices Sales Share by Application (2021-2032) Figure 60. Asia Wearable Injectors and Connected Devices Revenue Share by Country (2021-2032) Figure 61. Asia Wearable Injectors and Connected Devices Sales Share by Country (2021-2032) Figure 62. SAMEA Wearable Injectors and Connected Devices Revenue Share by Type (2021-2032) Figure 63. SAMEA Wearable Injectors and Connected Devices Sales Share by Type (2021-2032) Figure 64. SAMEA Wearable Injectors and Connected Devices Revenue Share by Application (2021-2032) Figure 65. SAMEA Wearable Injectors and Connected Devices Sales Share by Application (2021-2032) Figure 66. SAMEA Wearable Injectors and Connected Devices Revenue Share by Country (2021-2032) Figure 67. SAMEA Wearable Injectors and Connected Devices Sales Share by Country (2021-2032)

Scope & coverage.

Types
  • Disposable
  • Reusable
Applications
  • Home Care Settings
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Roche
  • Ypsomed
  • West Pharma
  • United Therapeutics
  • Unilife Corporation
  • Sonceboz
  • ScPharmaceuticals
  • Owen Mumford
  • Noble International
  • Insulet
  • Gerresheimer
  • Enable Injections
  • Elcam Medical
  • Eitan Medical
  • CeQur
  • BD Medical
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Wearable Injectors and Connected Devices Market by Type
  3. 1.2.1 Global Wearable Injectors and Connected Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Disposable
  5. 1.2.3 Reusable
  6. 1.3 Wearable Injectors and Connected Devices Market by Application
  7. 1.3.1 Global Wearable Injectors and Connected Devices Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Home Care Settings
  9. 1.3.3 Hospitals
  10. 1.3.4 Clinics
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Wearable Injectors and Connected Devices Market Dynamics
  1. 2.1 Wearable Injectors and Connected Devices Industry Trends
  2. 2.2 Wearable Injectors and Connected Devices Industry Drivers
  3. 2.3 Wearable Injectors and Connected Devices Industry Opportunities and Challenges
  4. 2.4 Wearable Injectors and Connected Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Wearable Injectors and Connected Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Wearable Injectors and Connected Devices Revenue by Region
  3. 3.2.1 Global Wearable Injectors and Connected Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Wearable Injectors and Connected Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Wearable Injectors and Connected Devices Sales by Region
  9. 3.4.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Wearable Injectors and Connected Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Wearable Injectors and Connected Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Wearable Injectors and Connected Devices Revenue by Manufacturers
  2. 4.1.1 Global Wearable Injectors and Connected Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Wearable Injectors and Connected Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Wearable Injectors and Connected Devices Sales by Manufacturers
  6. 4.2.1 Global Wearable Injectors and Connected Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Wearable Injectors and Connected Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Wearable Injectors and Connected Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Wearable Injectors and Connected Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Wearable Injectors and Connected Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Wearable Injectors and Connected Devices Manufacturers, Product Type & Application
  13. 4.7 Global Wearable Injectors and Connected Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Wearable Injectors and Connected Devices Market CR5 and HHI
  16. 4.8.2 2025 Wearable Injectors and Connected Devices Tier 1, Tier 2, and Tier 3
5 Wearable Injectors and Connected Devices Market by Type
  1. 5.1 Global Wearable Injectors and Connected Devices Revenue by Type
  2. 5.1.1 Global Wearable Injectors and Connected Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Wearable Injectors and Connected Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Wearable Injectors and Connected Devices Sales by Type
  6. 5.2.1 Global Wearable Injectors and Connected Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Wearable Injectors and Connected Devices Price by Type
6 Wearable Injectors and Connected Devices Market by Application
  1. 6.1 Global Wearable Injectors and Connected Devices Revenue by Application
  2. 6.1.1 Global Wearable Injectors and Connected Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Wearable Injectors and Connected Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Wearable Injectors and Connected Devices Sales by Application
  6. 6.2.1 Global Wearable Injectors and Connected Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Wearable Injectors and Connected Devices Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Wearable Injectors and Connected Devices Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Ypsomed
  8. 7.2.1 Ypsomed Company Information
  9. 7.2.2 Ypsomed Business Overview
  10. 7.2.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
  12. 7.2.5 Ypsomed Recent Developments
  13. 7.3 West Pharma
  14. 7.3.1 West Pharma Company Information
  15. 7.3.2 West Pharma Business Overview
  16. 7.3.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
  18. 7.3.5 West Pharma Recent Developments
  19. 7.4 United Therapeutics
  20. 7.4.1 United Therapeutics Company Information
  21. 7.4.2 United Therapeutics Business Overview
  22. 7.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
  24. 7.4.5 United Therapeutics Recent Developments
  25. 7.5 Unilife Corporation
  26. 7.5.1 Unilife Corporation Company Information
  27. 7.5.2 Unilife Corporation Business Overview
  28. 7.5.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
  30. 7.5.5 Unilife Corporation Recent Developments
  31. 7.6 Sonceboz
  32. 7.6.1 Sonceboz Company Information
  33. 7.6.2 Sonceboz Business Overview
  34. 7.6.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
  36. 7.6.5 Sonceboz Recent Developments
  37. 7.7 ScPharmaceuticals
  38. 7.7.1 ScPharmaceuticals Company Information
  39. 7.7.2 ScPharmaceuticals Business Overview
  40. 7.7.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
  42. 7.7.5 ScPharmaceuticals Recent Developments
  43. 7.8 Owen Mumford
  44. 7.8.1 Owen Mumford Company Information
  45. 7.8.2 Owen Mumford Business Overview
  46. 7.8.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
  48. 7.8.5 Owen Mumford Recent Developments
  49. 7.9 Noble International
  50. 7.9.1 Noble International Company Information
  51. 7.9.2 Noble International Business Overview
  52. 7.9.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
  54. 7.9.5 Noble International Recent Developments
  55. 7.10 Insulet
  56. 7.10.1 Insulet Company Information
  57. 7.10.2 Insulet Business Overview
  58. 7.10.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
  60. 7.10.5 Insulet Recent Developments
  61. 7.11 Gerresheimer
  62. 7.11.1 Gerresheimer Company Information
  63. 7.11.2 Gerresheimer Business Overview
  64. 7.11.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
  66. 7.11.5 Gerresheimer Recent Developments
  67. 7.12 Enable Injections
  68. 7.12.1 Enable Injections Company Information
  69. 7.12.2 Enable Injections Business Overview
  70. 7.12.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
  72. 7.12.5 Enable Injections Recent Developments
  73. 7.13 Elcam Medical
  74. 7.13.1 Elcam Medical Company Information
  75. 7.13.2 Elcam Medical Business Overview
  76. 7.13.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
  78. 7.13.5 Elcam Medical Recent Developments
  79. 7.14 Eitan Medical
  80. 7.14.1 Eitan Medical Company Information
  81. 7.14.2 Eitan Medical Business Overview
  82. 7.14.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
  84. 7.14.5 Eitan Medical Recent Developments
  85. 7.15 CeQur
  86. 7.15.1 CeQur Company Information
  87. 7.15.2 CeQur Business Overview
  88. 7.15.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
  90. 7.15.5 CeQur Recent Developments
  91. 7.16 BD Medical
  92. 7.16.1 BD Medical Company Information
  93. 7.16.2 BD Medical Business Overview
  94. 7.16.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
  96. 7.16.5 BD Medical Recent Developments
  97. 7.17 Amgen
  98. 7.17.1 Amgen Company Information
  99. 7.17.2 Amgen Business Overview
  100. 7.17.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
  102. 7.17.5 Amgen Recent Developments
8 North America
  1. 8.1 North America Wearable Injectors and Connected Devices Market Size by Type
  2. 8.1.1 North America Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Wearable Injectors and Connected Devices Price by Type (2021-2032)
  5. 8.2 North America Wearable Injectors and Connected Devices Market Size by Application
  6. 8.2.1 North America Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Wearable Injectors and Connected Devices Price by Application (2021-2032)
  9. 8.3 North America Wearable Injectors and Connected Devices Market Size by Country
  10. 8.3.1 North America Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Wearable Injectors and Connected Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Wearable Injectors and Connected Devices Market Size by Type
  2. 9.1.1 Europe Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Wearable Injectors and Connected Devices Price by Type (2021-2032)
  5. 9.2 Europe Wearable Injectors and Connected Devices Market Size by Application
  6. 9.2.1 Europe Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Wearable Injectors and Connected Devices Price by Application (2021-2032)
  9. 9.3 Europe Wearable Injectors and Connected Devices Market Size by Country
  10. 9.3.1 Europe Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Wearable Injectors and Connected Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Wearable Injectors and Connected Devices Market Size by Type
  2. 10.1.1 China Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  4. 10.1.3 China Wearable Injectors and Connected Devices Price by Type (2021-2032)
  5. 10.2 China Wearable Injectors and Connected Devices Market Size by Application
  6. 10.2.1 China Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  8. 10.2.3 China Wearable Injectors and Connected Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Wearable Injectors and Connected Devices Market Size by Type
  2. 11.1.1 Asia Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Wearable Injectors and Connected Devices Price by Type (2021-2032)
  5. 11.2 Asia Wearable Injectors and Connected Devices Market Size by Application
  6. 11.2.1 Asia Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Wearable Injectors and Connected Devices Price by Application (2021-2032)
  9. 11.3 Asia Wearable Injectors and Connected Devices Market Size by Country
  10. 11.3.1 Asia Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Wearable Injectors and Connected Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Wearable Injectors and Connected Devices Market Size by Type
  2. 12.1.1 SAMEA Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Wearable Injectors and Connected Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Wearable Injectors and Connected Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Wearable Injectors and Connected Devices Market Size by Application
  6. 12.2.1 SAMEA Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Wearable Injectors and Connected Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Wearable Injectors and Connected Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Wearable Injectors and Connected Devices Market Size by Country
  10. 12.3.1 SAMEA Wearable Injectors and Connected Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Wearable Injectors and Connected Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Wearable Injectors and Connected Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Wearable Injectors and Connected Devices Value Chain Analysis
  2. 13.1.1 Wearable Injectors and Connected Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Wearable Injectors and Connected Devices Production Mode & Process
  6. 13.2 Wearable Injectors and Connected Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Wearable Injectors and Connected Devices Distributors
  9. 13.2.3 Wearable Injectors and Connected Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst